These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1976270)

  • 21. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of famotidine in patients with reflux oesophagitis.
    Gladziwa U; Wagner S; Dakshinamurty KV; el Desoky E; Dreuw B; Klotz U
    Eur J Clin Pharmacol; 1993; 44(4):357-60. PubMed ID: 8513846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
    Collen MJ; Strong RM
    Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
    Akahoshi T; Kawanaka H; Tomikawa M; Saeki H; Uchiyama H; Ikeda T; Shirabe K; Hashizume M; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):483-9. PubMed ID: 24693675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daytime reduction of gastro-oesophageal reflux after healing of oesophagitis and its value as an indicator of favourable response to maintenance treatment.
    Pace F; Sangaletti O; Bianchi Porro G
    Gut; 1990 Sep; 31(9):1025-9. PubMed ID: 2210448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy.
    Masclee AA; de Best AC; de Graaf R; Cluysenaer OJ; Jansen JB
    Scand J Gastroenterol; 1990 Mar; 25(3):225-30. PubMed ID: 2181620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis.
    Lieberman DA
    Dig Dis Sci; 1988 Feb; 33(2):166-71. PubMed ID: 3338365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis.
    Simon TJ; Roberts WG; Berlin RG; Hayden LJ; Berman RS; Reagan JE
    Clin Ther; 1995; 17(6):1147-56. PubMed ID: 8750406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of gastroesophageal reflux as a cause of idiopathic hoarseness.
    McNally PR; Maydonovitch CL; Prosek RA; Collette RP; Wong RK
    Dig Dis Sci; 1989 Dec; 34(12):1900-4. PubMed ID: 2598757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in manometry and 24-H ambulatory pH-metry between patients with and without endoscopic or histological esophagitis in gastroesophageal reflux disease.
    Kasapidis P; Xynos E; Mantides A; Chrysos E; Demonakou M; Nikolopoulos N; Vassilakis JS
    Am J Gastroenterol; 1993 Nov; 88(11):1893-9. PubMed ID: 8237938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized comparative study of omeprazole and famotidine in reflux esophagitis.
    Kawano S; Murata H; Tsuji S; Kubo M; Tatsuta M; Iishi H; Kanda T; Sato T; Yoshihara H; Masuda E; Noguchi M; Kashio S; Ikeda M; Kaneko A
    J Gastroenterol Hepatol; 2002 Sep; 17(9):955-9. PubMed ID: 12167115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis.
    Ruth M; Enbom H; Lundell L; Lönroth H; Sandberg N; Sandmark S
    Scand J Gastroenterol; 1988 Nov; 23(9):1141-6. PubMed ID: 3073525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
    Mainguet P
    Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis.
    Sekiguchi T; Nishioka T; Matsuzaki T; Sugiyama M; Kusano M; Horikoshi T; Toki M; Ohwada T; Kobayashi S
    Gastroenterol Jpn; 1991 Apr; 26(2):137-44. PubMed ID: 2040397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of twice daily doses of 40 or 20 milligrams famotidine or 150 milligrams ranitidine for treatment of patients with moderate to severe erosive esophagitis. Famotidine Erosive Esophagitis Study Group.
    Simon TJ; Berlin RG; Tipping R; Gilde L
    Scand J Gastroenterol; 1993 May; 28(5):375-80. PubMed ID: 8511496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.
    Kusunoki H; Kusaka M; Kido S; Yamauchi R; Fujimura Y; Watanabe Y; Kobori M; Miwa H; Tomita T; Kin Y; Hori K; Tano N; Sugimoto K; Nakamura Y; Fujimoto K; Oza N; Matsunobu A; Ono N; Fuyuno S; Kinoshita Y; Adachi K; Yuki M; Fujisawa T; Haruma K
    J Gastroenterol; 2009; 44(4):261-70. PubMed ID: 19280112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
    Mine S; Fujisaki T; Tabata T; Matsuoka H; Iida T; Yamada S; Tanaka Y; Morimoto I; Eto S; Aibe T
    Am J Gastroenterol; 2000 Feb; 95(2):381-6. PubMed ID: 10685739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.